Acute liver injury in a non-alcoholic fatty liver disease patient with chloroform exposure: a case report

Letter Gastroenterology & Hepatology

Nonalcoholic Fatty Liver Disease for the Incidence of Drug-Induced Liver Injury

Seohwa Hwang et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Add to Collection

Letter Gastroenterology & Hepatology

Reply Towards a Simple Therapeutically Oriented Classification of Gastric Varices

Zachary Henry et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Add to Collection

Article Gastroenterology & Hepatology

The transition in the etiologies of hepatocellular carcinoma-complicated liver cirrhosis in a nationwide survey of Japan

Hirayuki Enomoto et al.

Summary: Viral hepatitis has remained the main cause of HCC in Japan, but the decrease in viral hepatitis-related HCC, particularly HCV-related HCC, has led to changes in etiology. Non-viral HCC, especially NASH-related HCC, has shown an increasing trend, contributing to the changing etiologies of HCC-complicated LC in Japan.

JOURNAL OF GASTROENTEROLOGY (2021)

Add to Collection

Review Gastroenterology & Hepatology

Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020

Katsutoshi Tokushige et al.

Summary: Nonalcoholic fatty liver disease (NAFLD) is a serious public health issue in Japan, with nonalcoholic steatohepatitis (NASH) being a progressive form that can lead to liver cirrhosis and increase the risk of hepatocellular carcinoma. The most common cause of death in NAFLD patients is cardiovascular disease.

JOURNAL OF GASTROENTEROLOGY (2021)

Add to Collection

Article Gastroenterology & Hepatology